Göritzer and colleagues investigate secretory IgA (SIgA) for mucosal delivery, complementing COVID-19 vaccination. SIgA demonstrates superior virus neutralization over IgG, proving protective in murine models. Aerosolizable for topical delivery via a mesh nebulizer, SIgAs have emerged as a promising tool to combat SARS-CoV-2.
All Keywords
【저자키워드】 passive immunization, SARS-CoV-2, monoclonal antibodies, Virus neutralization, secretory IgA, mucosal antibodies, Nicotiana benthamiana, topical delivery, molecular pharming,
【저자키워드】 passive immunization, SARS-CoV-2, monoclonal antibodies, Virus neutralization, secretory IgA, mucosal antibodies, Nicotiana benthamiana, topical delivery, molecular pharming,